Angiogenesis: bench to bedside, have we learned anything?

Toxicologic Pathology
Seung Uk LeeRoger J Laham

Abstract

End-stage ischemic cardiomyopathy patients are an ever-increasing group of coronary artery disease patients, often with no options in our current treatment armamentarium. Angiogenesis therapy pre-clinical and phase I clinical trials showed great promise, however, the benefits of single growth factor treatments have not been borne out in the larger phase II randomized trials. The complexity of angiogenesis process and the challenges in creating animal models to replicate and study this process in ischemic adult human myocardium have been major limitations to progress in this field. In addition failure to control for the powerful placebo effect in the clinical trials and inadequate methods of outcomes measures assessment have created difficult to overcome road blocks in establishing the efficacy of angiogenic strategies. Herein we review the challenges of angiogenesis research and development of treatment strategies. We also propose a structured model for further investigations of angiogenic therapies. The adherence to such a regimented approach as proposed here is, in our opinion, the only way to achieve success in angiogenesis approach development to treatment of patients with end-stage cardiac ischemia refractory to other esta...Continue Reading

References

Jan 1, 1983·The American Journal of Cardiology·E L JonesN Riechwald
Dec 1, 1993·Journal of the American College of Cardiology·A BattlerM Eldar
Dec 17, 1994·Lancet·J M Isner, L J Feldman
Jan 1, 1997·European Heart Journal·J M Isner
Mar 12, 1998·Circulation·J Folkman
Apr 16, 1998·Circulation·J Folkman
Jan 1, 1996·Vascular Medicine·J M Isner
Jul 1, 1998·The Annals of Thoracic Surgery·F W SellkeM Simons
Jan 20, 1999·Cardiovascular Research·J J LopezM Simons
Sep 11, 1999·The American Journal of Cardiology·D MukherjeeS G Ellis
Apr 11, 2000·Journal of the American College of Cardiology·H P Dustan
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·D J MarshallJ M Leiden
Feb 13, 2001·Annual Review of Medicine·R J LahamF Sellke
Dec 1, 2001·Expert Opinion on Biological Therapy·R J LahamF Sellke
Mar 20, 2002·Circulation·Cindy L GrinesRobert L Engler
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·Takayuki Asahara, Jeffrey M Isner
Jun 8, 2002·Current Pharmaceutical Design·Justin D PearlmanMichael Simons
Jul 2, 2002·The Journal of Thoracic and Cardiovascular Surgery·Marc RuelFrank W Sellke
Jan 9, 2003·Lancet·Roger J Laham, Peter Oettgen
Feb 21, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Roger J LahamFrank W Sellke
Mar 19, 2003·Zeitschrift für Kardiologie·E GrubeL Büllesfeld
Mar 19, 2003·Circulation·Timothy D HenryUNKNOWN VIVA Investigators
Apr 24, 2004·Journal of Interventional Cardiology·Thomas A Hennebry, Jorge F Saucedo
May 21, 2004·Expert Review of Cardiovascular Therapy·Audrey RosinbergRojer J Laham
May 28, 2004·Expert Opinion on Pharmacotherapy·Sheila A Doggrell
Jun 3, 2004·Journal of the American College of Cardiology·Angela HoyePatrick W Serruys
Aug 3, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·John Waugh, Antona J Wagstaff
Oct 19, 2004·Journal of the American College of Cardiology·Joseph S AlpertElizabeth Ofili
May 10, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Roger J LahamFrank W Sellke

❮ Previous
Next ❯

Citations

Feb 27, 2007·Basic Research in Cardiology·Naoichiro HattanPetra Rocic
May 7, 2009·Antioxidants & Redox Signaling·June YunWilliam M Chilian
Jan 8, 2008·Plastic and Reconstructive Surgery·Matthew J CallaghanGeoffrey C Gurtner
Feb 22, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Rashmi JadhavPetra Rocic
Oct 27, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Ryan ReedPetra Rocic
Jun 23, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Annamalai SenthilkumarChristopher G Kevil

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
René Houtman, Edwin van den Worm
© 2021 Meta ULC. All rights reserved